Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # FDA Approval
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Research Finds Out How Location Influences Immune System’s Ability to Fight Disease, Supports Vaccines and Immunotherapy

29 January 2025

Amgen’s Imdelltra® (tarlatamab-dlle) Significantly Reduces Risk of Death by 40% in Small Cell Lung Cancer Phase 3 Trial

2 June 2025

How the molecular dynamics of CAR T cells influence their ability to cancer-killing behavior

13 January 2025

Engineers Converted Skin Cells to Neurons for Cell Therapy Purpose

16 March 2025

Research: Scientists developed a novel radiotracer for the earlier detection of diseases

22 February 2024

ELISA-Enzyme Linked Immunosorbent Assay

13 June 2023

Stem Cells – Classification, Types, and Applications

12 July 2023

Researchers found antibiotic-resistant bacteria using bioinformatics tools

24 September 2024

HPLC – High-Performance Liquid Chromatography

2 September 2023

New Vaccine Developed for Lassa Fever; ready for Phase 1 Trials

13 September 2024

An experimental monoclonal antibody drug called mAb43 can protect pancreas cells from immune system attack

9 May 2024

Researchers Reveal Alarming Variations in a Key Cancer Immunotherapy Target Between Humans and Mice

7 January 2025

Danuglipron

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist
Business Clinical Investigation Healthcare & Pharmaceuticals News

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist

Ajmal Aseem 14 April 2025

Data from the danuglipron clinical development program will be presented at a scientific meeting or published in a peer-reviewed journal in the future.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy